A phase I trial of autologous CD34+ hematopoietic progenitor cells transduced with an anti-HIV ribozyme.
Amado
R G
RG
Department of Medicine and UCLA AIDS Institute, Los Angeles, CA 90095-1678, USA.
Mitsuyasu
R T
RT
Symonds
G
G
Rosenblatt
J D
JD
Zack
J
J
Sun
L Q
LQ
Miller
M
M
Ely
J
J
Gerlach
W
W
D000293:Adolescent; D000328:Adult; D018952:Antigens, CD34; D002478:Cells, Cultured; D002985:Clinical Protocols; D015696:Gene Products, tat / Q000235:genetics*; D015316:Genetic Therapy; D015658:HIV Infections / Q000628:therapy* / Q000821:virology; D006412:Hematopoietic Stem Cells / Q000276:immunology / Q000378:metabolism*; D006805:Human Experimentation; D006801:Humans; D008875:Middle Aged; D016337:RNA, Catalytic / Q000235:genetics*; D054322:tat Gene Products, Human Immunodeficiency Virus
D018952:Antigens, CD34; D015696:Gene Products, tat; D016337:RNA, Catalytic; D054322:tat Gene Products, Human Immunodeficiency Virus